vcfirmsdirectory.com

Venture capital · Early stage · Est. 2021

Cure Ventures

Boston-based life sciences venture capital firm that forms new therapeutics companies from scratch with scientist-entrepreneurs, backing them at seed and embedding experienced operators.

BostonRegistered · Boston
New investments · 12 months
Fund vehiclesPublic
2
2 active · US private fund
First cheque
Active portfolio
FreeRegistry entries, fund vehicles and filingsPROEverything we enrich: deals, team, events and signals
Updated 25 Oct 2026, 02:04 CETSources: curevc.com · SEC adviser filings

Investment activity

Round-by-round activity is part of PRO

See every round Cure Ventures joined

Monthly deal flow, follow-ons, fund closes and exits.

Key signal this week

See all signals

Is Cure Ventures right for your round?

Is Cure Ventures a fit for your round?

Match your sector, round, size and region against where they invest, and see who to approach.

Key stats

Fund vehiclesPublic
2
2 active · US private fund
SEC adviser filings
First cheque
Core stage
New deals per year
Lead rate
Active portfolio
Exits

Fund cycle Public record

Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.

CURE VENTURES FUND I, L.P.US private fund · Active · United States · $360.8M gross assets · filed 11 Mar 2026
CURE VENTURES FUND II, L.PUS private fund · Active · United States · $329.2M gross assets · filed 11 Mar 2026
Deployed (new cheques)
Next fund expected

Latest investments

Rounds Cure Ventures joined, from press and the firm’s own posts.

DateCompanyRoundRound sizeRoleAlongside

Every round Cure Ventures joined

Round sizes, Cure Ventures’s role and who invested alongside.

Round-by-round history is part of PRO

Notable portfolio

Aevum TherapeuticsAlessa TherapeuticsClasp TherapeuticsCrosslink TherapeuticsKenai TherapeuticsKobuk TherapeuticsPermeasisRecuro HealthTasca TherapeuticsTortugas Neuroscienceand 2 more

Portfolio and exits

Every company Cure Ventures backed and how the exits played out.

Where the money goes

Share of companies at first investment, from the rounds we track.

Where Cure Ventures puts its money

Sector, country and stage mix across every first cheque.

Investment team

The investment team

Partners, principals and investors, with their city, focus and how to reach them.

Where to meet Cure Ventures

Events where Cure Ventures’s team spoke or showed up, from event programmes, press and the firm’s own posts.

Where to meet Cure Ventures’s partners

The events they speak at, your next chance to meet them, and which ones founders can get into.

Signals

Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.

11 Mar 2026Fund filingForm ADV filed by CURE VENTURES MANAGEMENT, LP: 2 private funds, $690M in gross assets.SEC Form ADV · public record

Founders also look at

Frequently asked questions

Cure Ventures is based in Boston, United States.

In 2021.

2 fund vehicles are on public registers (SEC adviser filings), including CURE VENTURES FUND I, L.P. and CURE VENTURES FUND II, L.P.

Stages: Seed. Sectors: Life sciences. From the firm’s own website.

Cure builds de novo biotech companies around curative technologies. It funds at seed to de-risk the science, uses genetic validation to raise the odds of success, and embeds experienced drug-development operators who work day to day alongside founders. From the firm’s own website.

Cure Ventures lists 12 portfolio companies on its website, including Aevum Therapeutics, Alessa Therapeutics, Clasp Therapeutics, Crosslink Therapeutics and Kenai Therapeutics.

Firms whose websites list some of the same companies include The Column Group, ANV MANAGEMENT, LLC and ARCH Venture Partners.

Know before Cure Ventures’s next round is announced.

PRO tracks Cure Ventures’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.

Cure VenturesGet Cure Ventures’s signals the day they landMonitor

Search the directory

Type a firm's name, a city or a country.